These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
83 related items for PubMed ID: 2475359
21. Hexamethylenebisacetamide-mediated induction of murine erythroleukemia cells: relationship between expression of beta major and beta minor globin genes, globin mRNA synthesis and commitment to erythroid differentiation. Gambari R. Biochem Int; 1983 Oct; 7(4):471-80. PubMed ID: 6679742 [Abstract] [Full Text] [Related]
22. Differential expression of the globin genes in human leukemia K562(S) cells induced to differentiate by hemin or butyric acid. Cioe L, McNab A, Hubbell HR, Meo P, Curtis P, Rovera G. Cancer Res; 1981 Jan; 41(1):237-43. PubMed ID: 6934848 [Abstract] [Full Text] [Related]
23. Potentiation of cytotoxicity of 1-beta-D-arabinofuranosylcytosine for K562 human leukemic cells by cadeguomycin. Suzuki H, Kim SH, Tanara M, Okazaki K, Okabe T, Wu RT, Tanaka N. Cancer Res; 1987 Feb 01; 47(3):713-7. PubMed ID: 3467840 [Abstract] [Full Text] [Related]
24. Dependence for the proliferative response to erythropoietin on an established erythroid differentiation program in a human hematopoietic cell line, UT-7. Nicolis S, Ottolenghi S, Papayannopoulou T, Baiocchi M, Migliaccio G, Adamson J, Migliaccio AR. Exp Hematol; 1993 May 01; 21(5):665-70. PubMed ID: 8513868 [Abstract] [Full Text] [Related]
25. 1-beta-D-arabinofuranosylcytosine activates serine/threonine protein kinases and c-jun gene expression in phorbol ester-resistant myeloid leukemia cells. Kharbanda S, Emoto Y, Kisaki H, Saleem A, Kufe D. Mol Pharmacol; 1994 Jul 01; 46(1):67-72. PubMed ID: 8058058 [Abstract] [Full Text] [Related]
26. Induction of erythroid differentiation of K562 human leukemic cells by herbimycin A, an inhibitor of tyrosine kinase activity. Honma Y, Okabe-Kado J, Hozumi M, Uehara Y, Mizuno S. Cancer Res; 1989 Jan 15; 49(2):331-4. PubMed ID: 2910452 [Abstract] [Full Text] [Related]
27. Wilms' tumor gene, WT1, mRNA is down-regulated during induction of erythroid and megakaryocytic differentiation of K562 cells. Phelan SA, Lindberg C, Call KM. Cell Growth Differ; 1994 Jun 15; 5(6):677-86. PubMed ID: 8086342 [Abstract] [Full Text] [Related]
28. Effects of chebulinic acid on differentiation of human leukemia K562 cells. Yi ZC, Wang Z, Li HX, Liu MJ, Wu RC, Wang XH. Acta Pharmacol Sin; 2004 Feb 15; 25(2):231-8. PubMed ID: 14769215 [Abstract] [Full Text] [Related]
29. Development of resistance to 1-beta-D-arabinofuranosylcytosine after high-dose treatment in childhood lymphoblastic leukemia: analysis of resistance mechanism in established cell lines. Kees UR, Ford J, Dawson VM, Piall E, Aherne GW. Cancer Res; 1989 Jun 01; 49(11):3015-9. PubMed ID: 2720661 [Abstract] [Full Text] [Related]
34. Activation of the LRP (lung resistance-related protein) gene by short-term exposure of human leukemia cells to phorbol ester and cytarabine. Komarov PG, Shtil AA, Holian O, Tee L, Buckingham L, Mechetner EB, Roninson IB, Coon JS. Oncol Res; 1998 Jun 01; 10(4):185-92. PubMed ID: 9778689 [Abstract] [Full Text] [Related]
36. Dysregulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1/MDA6 increases the susceptibility of human leukemia cells (U937) to 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial dysfunction and apoptosis. Wang Z, Van Tuyle G, Conrad D, Fisher PB, Dent P, Grant S. Cancer Res; 1999 Mar 15; 59(6):1259-67. PubMed ID: 10096557 [Abstract] [Full Text] [Related]